COLUMBUS, Ga., Oct. 27, 2021 /PRNewswire/ — Aflac Incorporated (NYSE: AFL) today reported its third quarter results.
Total revenues were $5.2 billion in the third quarter of 2021, compared with $5.7 billion in the third quarter of 2020. Net earnings were $888 million, or $1.32 per diluted share, compared with $2.5 billion, or $3.44 per diluted share a year ago. Net earnings in 2020 reflect a $1.4 billion benefit from the release of valuation allowances on deferred tax benefits due to changes in U.S. tax regulations.
Net earnings in the third quarter of 2021 included pretax adjusted net investment losses* of $172 million, or $0.26 per diluted share, compared with pretax adjusted net investment gains of $117 million, or $0.16 per diluted share a year ago, which are excluded from adjusted earnings*. The adjusted net investment losses were driven by a decrease in the fair value of equity securities of $119 million, net losses from certain derivatives and foreign currency activities of $39 million, net losses from sales and redemptions of $14 million, partially offset by a decrease in the allowance associated with the company’s estimate of current expected credit losses (CECL) of $1 million.
The average yen/dollar exchange rate* in the third quarter of 2021 was 110.11, or 3.5% weaker than the average rate of 106.23 in the third quarter of 2020. For the first nine months, the average exchange rate was 108.58, or 0.9% weaker than the rate of 107.63 a year ago.
Total investments and cash at the end of September 2021 were $146.0 billion, compared with $146.1 billion at September 30, 2020. In the third quarter, Aflac Incorporated deployed $525 million in capital to repurchase 9.6 million of its common shares. At the end of September 2021, the company had 67.0 million remaining shares authorized for repurchase.
Shareholders’ equity was $33.6 billion, or $50.62 per share, at September 30, 2021, compared with $32.5 billion, or $46.16 per share, at September 30, 2020. Shareholders’ equity at the end of the third quarter included a net unrealized gain on investment securities and derivatives of $9.7 billion, compared with a net unrealized gain of $9.5 billion at September 30, 2020. Shareholders’ equity at the end of the third quarter also included an unrealized foreign currency translation loss of $1.8 billion, compared with an unrealized foreign currency translation loss of $1.3 billion at September 30, 2020. The annualized return on average shareholders’ equity in the third quarter was 10.6%.
Adjusted earnings in the third quarter were $1.0 billion, compared with $994 million in the third quarter of 2020, reflecting an increase of 3.7% driven by lower-than-expected benefit ratios and higher net investment income, primarily in Japan, partially offset by a higher effective tax rate. Adjusted earnings included pretax variable investment income of $112 million on alternative investments, which was $96 million above long-term return expectations. Adjusted earnings per diluted share* increased 10.1% to $1.53 in the quarter. The weaker yen/dollar exchange rate impacted adjusted earnings per diluted share by $0.02.
For the first nine months of 2021, total revenues were up 2.7% to $16.7 billion, compared with $16.2 billion in the first nine months of 2020. Net earnings were $3.3 billion, or $4.82 per diluted share, compared with $3.8 billion, or $5.31 per diluted share, for the first nine months of 2020. Adjusted earnings for the first nine months of 2021 were $3.2 billion, or $4.65 per diluted share, compared with $2.8 billion, or $3.88 per diluted share, in 2020. Adjusted earnings included $283 million of pretax variable investment income on alternative investments, which was $232 million above long-term return expectations. Excluding the negative impact of $0.01 per share from the weaker yen/dollar exchange rate, adjusted earnings per diluted share increased 20.1% to $4.66 for the first nine months of 2021.
Shareholders’ equity excluding AOCI (or adjusted book value*) was $25.9 billion, or $39.06 per share at September 30, 2021, compared with $24.6 billion, or $34.91 per share, at September 30, 2020. The annualized adjusted return on equity excluding foreign currency impact* in the third quarter was 16.2%.
AFLAC JAPAN
In yen terms, Aflac Japan’s net premium income was ¥323.1 billion for the quarter, or 4.0% lower than a year ago, mainly due to limited-pay products reaching paid-up status and constrained sales from the impact of pandemic conditions. Adjusted net investment income increased 19.7% to ¥84.0 billion, mainly due to higher alternative and floating rate income and lower hedge costs. Total adjusted revenues in yen increased 0.1% to ¥408.2 billion. Pretax adjusted earnings in yen for the quarter increased 35.8% on a reported basis, due to higher net investment income and a decline in the third sector benefit ratio from a reserve release resulting from lower claims activity associated with pandemic conditions. Pretax adjusted earnings increased 33.7% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment was 26.3%, compared with 19.4% a year ago. The increase in the profit margin is largely due to continued improvements in incurred benefits and adjusted net investment income.
For the first nine months, premium income in yen was ¥980.7 billion, or 3.8% lower than a year ago. Adjusted net investment income increased 17.9% to ¥245.3 billion. Total adjusted revenues in yen were down 0.1% to ¥1.2 trillion. Pretax adjusted earnings were ¥311.3 billion, or 18.7% higher than a year ago.
In dollar terms, net premium income decreased 7.4% to $2.9 billion in the third quarter. Adjusted net investment income increased 15.1% to $763 million. Total adjusted revenues declined by 3.5% to $3.7 billion. Pretax adjusted earnings increased 30.7% to $976 million.
For the first nine months, premium income in dollars was $9.0 billion, or 4.5% lower than a year ago. Adjusted net investment income increased 16.6% to $2.3 billion. Total adjusted revenues were down 1.0% to $11.3 billion. Pretax adjusted earnings were $2.9 billion, or 17.4% higher than a year ago.
For the quarter, total new annualized premium sales (sales) were essentially flat at ¥12.6 billion, or $114 million, reflecting continued lower levels of face-to-face sales activity. For the first nine months, total new annualized premium sales (sales) increased 10.3% to ¥40.2 billion, or $371 million.
AFLAC U.S.
Aflac U.S. net premium income declined 1.0% to $1.4 billion in the third quarter, mainly due to constrained sales over the past year. Adjusted net investment income increased 9.1% to $191 million primarily due to higher variable net investment income. Total adjusted revenues were up 0.6% to $1.6 billion, largely due to the increase in adjusted net investment income. Pretax adjusted earnings were $358 million, 8.8% higher than a year ago, which was driven by lower incurred benefits and higher adjusted net investment income, partially offset by higher adjusted expenses, which were driven by the execution of the buy-to-build strategy. The pretax adjusted profit margin for the U.S. segment was 22.2%, compared with 20.5% a year ago.
For the first nine months, premium income declined 2.9% to $4.2 billion. Adjusted net investment income increased 6.5% to $557 million. Total adjusted revenues were down 1.6% to $4.9 billion. Pretax adjusted earnings were $1.2 billion, or 12.5% higher than a year ago.
Aflac U.S. sales increased 35.0% in the quarter to $299 million, reflecting increased face-to-face sales activity. For the first nine months of the year, total new sales increased 15.5% to $814 million.
CORPORATE AND OTHER
For the quarter, total adjusted revenues decreased 17.2% to $72 million, due to a $12 million decline in adjusted net investment income, primarily due to lower yields and the impact of federal tax credit investments, as tax benefits are recognized. Pretax adjusted earnings were a loss of $41 million, compared with a loss of $39 million a year ago, primarily reflecting lower adjusted net investment income.
For the first nine months of the year, total adjusted revenues decreased 29.8% to $205 million, primarily due to a $78 million decrease in adjusted net investment income. Pretax adjusted earnings were a loss of $144 million, compared with a loss of $69 million a year ago.
DIVIDEND
The board of directors declared the fourth quarter dividend of $0.33 per share, payable on December 1, 2021 to shareholders of record at the close of business on November 17, 2021.
OUTLOOK
Commenting on the company’s results, Chairman and Chief Executive Officer Daniel P. Amos stated: “The company generated strong earnings for the first nine months, largely supported by the continuation of low benefit ratios associated with pandemic conditions and better-than-expected returns from alternative investments. With respect to third quarter sales results, we continued to see improvement in the United States, whereas in Japan pandemic conditions were more challenging.
“Looking at our operations in Japan, third quarter sales were essentially flat year over year. We were encouraged by the September launch of our new nursing care product, which was off to a promising start, but will take time to have a measurable impact on our overall sales outlook. We continued to navigate evolving pandemic conditions in Japan, which included widespread states of emergency that persisted through the third quarter. As we enter the fourth quarter, the ability to meet face-to-face with customers appears to be improving gradually, and it will continue to be key to a recovery in sales.
“In the U.S., small businesses are still in recovery mode, which we expect to continue through the rest of the year. At the same time, larger businesses have been more resilient and have shown better potential for sales in the fourth quarter. We continue to work toward reinforcing our position and generating stronger sales for the remainder of 2021.
“As always, we remain committed to prudent liquidity and capital management. We continue to maintain strong capital ratios on behalf of our policyholders in both the U.S. and Japan. We treasure our record of dividend growth. With the fourth quarter’s declaration, 2021 will mark the 39th consecutive year of dividend increases. Our dividend track record is supported by the strength of our capital and cash flows. At the same time, we will continue to tactically repurchase shares, focused on integrating the growth investments we have made in our platform. By doing so, we look to emerge from this period in a continued position of strength and leadership.”
*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.
ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL) is a Fortune 500 company helping provide protection to more than 50 million people through its subsidiaries in Japan and the U.S., where it is a leading supplemental insurer by paying cash fast when policyholders get sick or injured. For more than six decades, insurance policies of Aflac Incorporated’s subsidiaries have given policyholders the opportunity to focus on recovery, not financial stress. Aflac Life Insurance Japan is the leading provider of medical and cancer insurance in Japan where it insures 1 in 4 households. For 15 consecutive years, Aflac Incorporated has been recognized by Ethisphere as one of the World’s Most Ethical Companies. In 2021, Fortune included Aflac Incorporated on its list of World’s Most Admired Companies for the 20th time, and Bloomberg added Aflac Incorporated to its Gender-Equality Index, which tracks the financial performance of public companies committed to supporting gender equality through policy development, representation and transparency, for the second consecutive year. To find out how to get help with expenses health insurance doesn’t cover, get to know us at aflac.com. Investors may learn more about Aflac Incorporated and its commitment to ESG and social responsibility at investors.aflac.com and esg.aflac.com.
A copy of Aflac’s Financial Analysts Briefing (FAB) supplement for the quarter can be found on the “Investors” page at aflac.com.
Aflac Incorporated will webcast its quarterly conference call via the “Investors” page of aflac.com at 9:00 a.m. (ET) on Thursday, October 28, 2021.
Note: Tables within this document may not foot due to rounding.
| AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT | |||||||||||
| (UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS) | |||||||||||
| THREE MONTHS ENDED SEPTEMBER 30, | 2021 | 2020 | % Change | ||||||||
| Total revenues | $ | 5,237 | $ | 5,665 | (7.6) | % | |||||
| Benefits and claims, net | 2,609 | 2,985 | (12.6) | ||||||||
| Total acquisition and operating expenses | 1,515 | 1,527 | (0.8) | ||||||||
| Earnings before income taxes | 1,113 | 1,153 | (3.5) | ||||||||
| Income taxes | 225 | (1,303) | |||||||||
| Net earnings | $ | 888 | $ | 2,456 | (63.8) | % | |||||
| Net earnings per share – basic | $ | 1.33 | $ | 3.45 | (61.4) | % | |||||
| Net earnings per share – diluted | 1.32 | 3.44 | (61.6) | ||||||||
| Shares used to compute earnings per share (000): | |||||||||||
| Basic | 668,762 | 711,698 | (6.0) | % | |||||||
| Diluted | 671,925 | 713,793 | (5.9) | ||||||||
| Dividends paid per share | $ | 0.33 | $ | 0.28 | 17.9 | % |
| AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT | |||||||||||
| (UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS) | |||||||||||
| NINE MONTHS ENDED SEPTEMBER 30, | 2021 | 2020 | % Change | ||||||||
| Total revenues | $ | 16,670 | $ | 16,234 | 2.7 | % | |||||
| Benefits and claims, net | 7,996 | 8,822 | (9.4) | ||||||||
| Total acquisition and operating expenses | 4,584 | 4,470 | 2.6 | ||||||||
| Earnings before income taxes | 4,090 | 2,942 | 39.0 | ||||||||
| Income taxes | 804 | (884) | |||||||||
| Net earnings | $ | 3,286 | $ | 3,826 | (14.1) | % | |||||
| Net earnings per share – basic | $ | 4.84 | $ | 5.33 | (9.2) | % | |||||
| Net earnings per share – diluted | 4.82 | 5.31 | (9.2) | ||||||||
| Shares used to compute earnings per share (000): | |||||||||||
| Basic | 678,509 | 717,962 | (5.5) | % | |||||||
| Diluted | 681,521 | 720,333 | (5.4) | ||||||||
| Dividends paid per share | $ | 0.99 | $ | 0.84 | 17.9 | % |
| AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET | |||||||||||
| (UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AMOUNTS) | |||||||||||
| SEPTEMBER 30, | 2021 | 2020 | % Change | ||||||||
| Assets: | |||||||||||
| Total investments and cash | $ | 146,004 | $ | 146,129 | (0.1) | % | |||||
| Deferred policy acquisition costs | 9,714 | 10,319 | (5.9) | ||||||||
| Other assets | 4,879 | 4,507 | 8.3 | ||||||||
| Total assets | $ | 160,597 | $ | 160,955 | (0.2) | % | |||||
| Liabilities and shareholders’ equity: | |||||||||||
| Policy liabilities | $ | 107,443 | $ | 111,587 | (3.7) | % | |||||
| Notes payable and lease obligations | 8,066 | 7,825 | 3.1 | ||||||||
| Other liabilities | 11,536 | 9,064 | 27.3 | ||||||||
| Shareholders’ equity | 33,552 | 32,479 | 3.3 | ||||||||
| Total liabilities and shareholders’ equity | $ | 160,597 | $ | 160,955 | (0.2) | % | |||||
| Shares outstanding at end of period (000) | 662,817 | 703,574 | (5.8) | % |
NON-U.S. GAAP FINANCIAL MEASURES
This document includes references to the Company’s financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.
Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the yen weakens, translating yen into dollars results in fewer dollars being reported. When the yen strengthens, translating yen into dollars results in more dollars being reported. Consequently, yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company’s business is conducted in yen and never converted into dollars but translated into dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company’s financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts on book value and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).
The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:
- Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company’s underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.
- Adjusted earnings excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company’s business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.
- Adjusted return on equity is adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income (AOCI). Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of AOCI, which fluctuate due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on average equity (ROE) as determined using net earnings and average total shareholders’ equity.
- Adjusted return on equity excluding foreign currency impact is adjusted earnings excluding the current period foreign currency impact divided by average shareholders’ equity, excluding AOCI. The Company considers adjusted return on equity excluding foreign currency impact important as it excludes changes in foreign currency and components of AOCI, which fluctuate due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency impact is ROE as determined using net earnings and average total shareholders’ equity.
- Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign exchange risks in the Company’s Japan segment or in the Corporate and Other segment. These amortized hedge costs/ income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the term of the hedge. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/ income.
- Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less AOCI as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude AOCI, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.
- Adjusted book value including unrealized foreign currency translation gains and losses is adjusted book value plus unrealized foreign currency translation gains and losses. Adjusted book value including unrealized foreign currency translation gains and losses per common share is adjusted book value plus unrealized foreign currency translation gains and losses at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value including unrealized foreign currency translation gains and losses, and its related per share financial measure, important as they exclude certain components of AOCI, which fluctuate due to market movements that are outside management’s control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measures for adjusted book value including unrealized foreign currency translation gains and losses and adjusted book value including unrealized foreign currency translation gains and losses per common share are total book value and total book value per common share, respectively.
- Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.
- Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest cash flows from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest cash flows from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.